Diagnostica Stago Inc., a foreign-owned manufacturer of medical devices and consumables for hemostasis and thrombosis testing, holds a multiple award Federal Supply Schedule (FSS) contract with the U.S. federal government to provide specialized coagulation analyzers, reagents, controls, and associated products and services. The $61.4 million contract, awarded by the Department of Veterans Affairs' (VA) Veterans Health Administration, enables federal agencies like the VA and Defense Health Agency (DHA) to rapidly acquire these critical laboratory testing capabilities through pre-established terms and conditions.
The contract provides prothrombin time, partial thromboplastin time, fibrinogen, and D-dimer testing to aid in evaluating bleeding disorders, clotting factor deficiencies, anticoagulation therapy management, and thrombosis risk in patients. Diagnostica Stago delivers its STA line of compact and automated hemostasis analyzers, specialty coagulation reagents and controls, and preventative maintenance or cost-per-test services to support clinical laboratory operations at VA and DOD medical facilities across the country. The contract has no set-aside designations and places of performance are located nationwide, enabling federal healthcare providers to obtain these essential diagnostic capabilities to enhance patient care and support medical research programs.
Generated 10/31/24, 9:03 AM